News Conference News ACC 2024 TARGET BP 1: Alcohol-Based RDN Promises Single Treatment for Resistant BP A novel approach to renal denervation led to improvements in ambulatory BP, but not office-based, in this sham-controlled trial. L.A. McKeown April 16, 2024
Presentation Fellows 2024 Peripheral Skills that Every Interventionalist MUST Learn in Fellowship Presenter: S. Jay Mathews April 14, 2024
Presentation Fellows 2024 Pulmonary Embolism and Venous Disease: The Hottest Frontier of Endovascular Intervention Presenter: Jay Giri April 14, 2024
Presentation Fellows 2024 Peripheral Case Potpourri: Head to Toe (Includes Carotid, Renal, and CLI) Presenter: Sanjum Sethi April 14, 2024
Presentation Fellows 2024 Renal Denervation for Hypertension: What You Need to Know Presenter: Ajay Kirtane April 14, 2024
Presentation Fellows 2024 Workup and Treatment of Lower-Extremity PAD: What All Interventionalists Need to Know Presenter: Sahil Parikh April 14, 2024
News Daily News BASIL-3: More Questions Than Answers About Drug-Coated Devices in CLTI By L.A. McKeown April 24, 2024
News Conference News ACC 2024 TARGET BP 1: Alcohol-Based RDN Promises Single Treatment for Resistant BP By L.A. McKeown April 16, 2024
News Conference News ACC 2024 IVUS Benefits Patients Receiving DCBs for Fem-Pop Disease By Caitlin E. Cox April 10, 2024
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for March 2024 By Shelley Wood April 03, 2024
News Daily News Class I Recall for 330,000 Radial Artery Catheterization Kits: FDA By Yael L. Maxwell April 03, 2024